Search / 5 results found

  • Updated

CAMBRIDGE, Mass., Oct. 25, 2021 /PRNewswire/ -- At Akebia Therapeutics, we are driven by a collective purpose to better the lives of people impacted by kidney disease. As part of our charge to support kidney disease patients, we work to develop and market innovative therapies and ensure that all patients, especially patients disproportionately impacted by chronic kidney disease (CKD), have access to and are reimbursed for these critical therapies.

  • Updated

(The Center Square) – The Fifth Circuit Court of Appeals upheld a 2017 Texas law outlawing a second trimester abortion procedure called D&E (dilation and evacuation), or dismemberment.